Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming. (2017)

First Author: Bernstock JD
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-07631-9

PubMed Identifier: 28785061

Publication URI: http://europepmc.org/abstract/MED/28785061

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322